NCT01326871 2024-06-25
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Altor BioScience
Phase 1/2 Completed
Altor BioScience
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
SWOG Cancer Research Network
SWOG Cancer Research Network